Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data

Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018

(2021) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Buprenorphine Treatment Divide by Race/Ethnicity and Payment

(2019) Pooja A. Lagisetty et al.   JAMA Psychiatry

Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder

(2019) Arthur Robin Williams et al.   AMERICAN JOURNAL OF PSYCHIATRY

Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder

(2018) Natalia Shcherbakova et al.   ANNALS OF PHARMACOTHERAPY

Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis

(2018) Jun Ma et al.   MOLECULAR PSYCHIATRY

Three-Year Retention in Buprenorphine Treatment for Opioid Use Disorder Among Privately Insured Adults

(2018) Ajay Manhapra et al.   PSYCHIATRIC SERVICES

Using Real-World Data to Extrapolate Evidence From Randomized Controlled Trials

(2018) Shirley V. Wang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population

(2017) Brendan Saloner et al.   MEDICAL CARE

Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study

(2015) Roger D. Weiss et al.   DRUG AND ALCOHOL DEPENDENCE

American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use

(2015) Kyle Kampman et al.   Journal of Addiction Medicine

Comparison of behavioral treatment conditions in buprenorphine maintenance

(2013) Walter Ling et al.   ADDICTION

Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.

(2012) Kelly E. Dunn et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trial

(2011) Anthony DeFulio et al.   DRUG AND ALCOHOL DEPENDENCE

Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance

(2010) G. Gerra et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY